About this trial
This is an retrospective and prospective (ambispective) study with data collection from volunteer patients who passed an MMPI-2-RF (Minnesota Multiphasic Personality Inventory-2-Restructured form) questionnaire in the preoperative phase of a bariatric surgery project.
The evolution of their BMI will be correlated to psychological dimensions collected in patient questionnaires, before and after bariatric surgery.
The presence of possible risk factors such as depression, anxiety, eating disorders, quality of life, satisfaction and the perception of body, could make it possible to establish adapted therapies before surgery, in order to attenuate or eliminate the presence of these factors, and improve BMI evolution and bariatric surgery success.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Having passed the MMPI-2-RF questionnaire between January 1, 2014 and December 31, 2023 in the preoperative phase, as part of psychological follow-up
Having benefited from bariatric surgery or patients who have abandoned the surgery plan for a reason other than a medical contraindication.
Informed of the study, having agreed to participate and not having opposed the use of their data
Disqualifiers
Subjects who generated an invalid MMPI-2-RF questionnaire, according to the test validity criteria (verified by the principal investigator)
Subjects who expressly objected to the use of their data for this study
Subjects who have not undergone bariatric surgery due to a medical contraindication.
Patient unable to understand the study or complete the post-operative phase visit
Trial population
Patients with severe obesity : BMI \> 40 kg/m2 or \> 35 kg/m2 associated with at least one comorbidity likely to be improved after surgery. * Failure of well-conducted medical, nutritional, dietetic and psychotherapeutic monitoring for 6-12 months * Lack of sufficient weight loss or failure to maintain weight loss
Trial design
Cohort
Other
Treatments tested in this trial
post-surgery psychological evaluation
BehavioralFollowing questionnaires will be done : Patient Health Questionnaire (PHQ-9) Generalized Anxiety Disorder (GAD-7) Three Factor Eating Questionnaire (TFEQ-R21) Quality of life for obesity and dietetic questionnaire (EQVOD) Body Esteem Scale (BES) Figure Rating Scale (auto-questionnaire)
Treatment groups
Trial outcomes
Primary outcomes
Determine the predictive value of depressive symptomatology dimension on the evolution of BMI.
Depressive dimension assessed by the preoperative MMPI-2-RF questionnaire and compared to the same dimension from post-surgery psychological questionnaires.
Secondary outcomes
Determine the predictive value of anxiety symptomatology dimension on the evolution of BMI
Anxiety dimension assessed by the preoperative MMPI-2-RF questionnaire and compared to the same dimension from post-surgery psychological questionnaires.
Determine the predictive value of eating behavior dimension on the evolution of BMI
Eating behaviour dimension assessed by the preoperative MMPI-2-RF questionnaire and compared to the same dimension from post-surgery psychological questionnaires.
Determine the predictive value of quality of life dimension on the evolution of BMI
Quality of life dimension assessed by the preoperative MMPI-2-RF questionnaire and compared to the same dimension from post-surgery psychological questionnaires.
Determine the predictive value of satisfaction and body perception dimensions on the evolution of BMI
satisfaction and body perception dimensions assessed by the preoperative MMPI-2-RF questionnaire and compared to the same dimension from post-surgery psychological questionnaires.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.